Research indicates that individuals adhering to an intermittent fasting regimen experienced an average weight loss of approximately 5.5 pounds, contrasting with a 3.7-pound gain observed in the control group. Blood analyses highlighted significant enhancements in inflammation and immune function markers, including lower levels of leptin and PAI-1, all achieved without caloric restrictions.
The study, published in Gastroenterology, emphasizes that those with inflammatory bowel disease (IBD) should consult healthcare professionals before modifying their eating patterns to assess the suitability of intermittent fasting.
Understanding Time-Restricted Feeding
Time-restricted feeding (TRF) involves consuming meals within a designated 8-hour timeframe daily, followed by a 16-hour fasting period. The 12-week investigation involved 35 adults diagnosed with Crohn's disease and classified as obese or overweight. Participants were divided into two groups: 20 followed the TRF approach, while 15 maintained their usual dietary habits. Evaluations of disease activity, inflammation, and body composition were conducted at the study's onset and conclusion.
According to Dr. Maitreyi Raman, a senior author and Associate Professor of Medicine at the University of Calgary, "This study demonstrates that while weight loss is crucial for individuals with Crohn's disease and excess weight, time-restricted feeding delivers additional benefits beyond mere weight measurement." The study reported notable improvements in disease symptoms, reduced abdominal discomfort, positive metabolic and inflammatory changes, and beneficial alterations in gut microbiota, suggesting that intermittent fasting may assist patients in achieving sustained remission from Crohn's disease.
Endorsement from the Crohn's & Colitis Foundation
The research was supported by the Crohn's & Colitis Foundation's Litwin IBD Pioneers program. Dr. Andres Lorenzo Hurtado, Senior Vice President of Translational Research & IBD Ventures at the Foundation, stated, "Time-restricted feeding is emerging as a promising strategy for individuals with Crohn's disease to manage their symptoms and overall health." He added that modifying meal timing, not just dietary content, may enhance metabolism, bolster immune function, and foster long-term remission from Crohn's disease. The Foundation is eager to back research that prioritizes patient-centric solutions and advocates for further studies to ensure these advantages are accessible to all IBD patients.
Dr. Natasha Haskey, a Research Associate at the University of British Columbia and lead investigator, noted, "Patients with Crohn's disease often seek practical strategies to complement their treatment. Our findings suggest that time-restricted eating could be a biologically grounded, sustainable method for patients to enhance their wellness."
Decreased Visceral Fat and Inflammation
In addition to symptom relief, participants following the intermittent fasting protocol showed a significant reduction in harmful visceral fat and key inflammatory markers in their blood. Since both groups consumed similar foods in comparable quantities, these improvements cannot be attributed solely to dietary quality or caloric intake. The results indicate that meal timing may significantly influence digestive and immune health.
While these findings are promising, researchers emphasize the necessity for larger studies to assess the long-term safety and efficacy of time-restricted feeding among a wider population of individuals with IBD.
This research received funding from the Crohn's & Colitis Foundation, Litwin IBD Pioneers Grant (ID: 879104), and Imagine Network (University of Calgary).
